Pre-market hot trades in US stocks: Real Messenger pre-market down 9.25%; Neo-Concept pre-market down 8.97%

Pre-market Hot Trades in US Stocks Real Messenger is down 9.25% in pre-market trading. Based on recent key news: On April 15, Real Messenger's stock price fell 24.58%, primarily due to technical analysis indicating that its stock price was significantly above both short-term and long-term moving averages, raising concerns about its overvaluation. The stock price at the time of the announcement was $1.81, below the key support level of $1.50, indicating market uncertainty about its future trend. Source: Benzinga On April 15, technical indicators showed a relative strength index (RSI) of 78.77, indicating that the stock price is in an overbought state, which may trigger profit-taking by investors. Source: Benzinga On April 15, long-term technical analysis indicated a death cross in November 2025, with the 50-day moving average falling below the 200-day moving average, which may exert long-term pressure on the stock price. Source: Benzinga Technical indicators show overbought conditions, necessitating caution regarding volatility risks. Neo-Concept is down 8.97% in pre-market trading. Based on recent key news: On April 16, Benzinga Pro's signal feature indicated that NCI stocks may experience a breakout. This signal attracted market attention, leading to increased investor interest in related stocks, which in turn affected Neo-Concept's stock price volatility. On April 16, documents released by the EDGAR system showed that Neo-Concept employs a dual-class share structure, with its main executive office located in Hong Kong. This information may raise market concerns about the company's governance structure, affecting investor confidence. On April 17, technical sentiment signals indicated a sell, with market sentiment towards Neo-Concept leaning negative, putting pressure on the stock price. There is increased market attention on the dual-class share structure. Top Gainers in Pre-market US Stocks Psyence Biomedical is up 86.52% in pre-market trading. Based on recent news: On April 15, Psyence Biomedical announced collaborations with experienced hospitals and professional research partners, supplying NPX-5 from its GMP-certified facilities, aimed at accelerating patient recruitment, improving operational efficiency, and solidifying its position in the emerging psychedelic clinical field. This news significantly boosted the stock price. On April 16, Easywell Biomedicals' subsidiary Tulex Pharmaceuticals submitted a new drug application for TLX-042, a liquid oral anti-epileptic drug, to the US FDA. This development may have a positive impact on overall industry sentiment. On April 17, Penetrium Bioscience showcased its complete dataset and global clinical development roadmap at the AACR 2026 annual meeting, attracting leading oncology experts and multinational pharmaceutical companies. This event may positively impact the biopharmaceutical industry, which has been performing strongly recently, with heightened investor sentiment YXT.COM, pre-market up 57.68%, no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Able View Global, pre-market up 42.24%, no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation